Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30082367HIVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS30083917HIVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS30088546HIVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS20028144HPVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS20069786HPVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS20063474HPVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS20063725HPVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS20064042HPVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS20063675HPVENSG00000165025.15protein_codingSYKYesNo6850P43405
TVIS44026298HTLV-1ENSG00000165025.15protein_codingSYKYesNo6850P43405
TCGA Plot Options
Drug Information
GeneSYK
DrugBank IDDB12121
Drug NameEntospletinib
Target IDBE0001316
UniProt IDP43405
Regulation Typeinhibitor
PubMed IDs33689480
CitationsZheng TJ, Lofurno ER, Melrose AR, Lakshmanan HHS, Pang J, Phillips KG, Fallon ME, Kohs TCL, Ngo ATP, Shatzel JJ, Hinds MT, McCarty OJT, Aslan JE: Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function. Am J Physiol Cell Physiol. 2021 May 1;320(5):C902-C915. doi: 10.1152/ajpcell.00296.2020. Epub 2021 Mar 10.
GroupsInvestigational
Direct ClassificationPhenylmorpholines
SMILESC1CN(CCO1)C1=CC=C(NC2=NC(=CN3C=CN=C23)C2=CC3=C(C=NN3)C=C2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL3265032